William L. Greene, PharmD

Member, St. Jude Faculty
Chief Pharmaceutical Officer

Departments

Pharmaceutical Sciences
Administration

Contact Information

William Greene, PharmD
Pharmaceutical Sciences
MS 150, Room BP024F
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: william.greene@stjude.org
Phone: (901) 595-3686
FAX: (901) 595-3111

Education

BS (Pharmacy) - University of North Carolina, Chapel Hill (1979)
PharmD - University of Tennessee Center for Health Sciences, Memphis (1981)
Residency – Hospital Pharmacy, Duke University Hospital/Medical Center (1982)

Honors & Awards

• 2010  National Community Pharmacists Association (NCPA) Pharmacy Leadership Award
• 2010  Tennessee Society of Health-System Pharmacists’/National Community Pharmacists’ Association Pharmacy Leadership Award
• 2008  Tennessee Society of Health-System Pharmacists’ Past President Award
• 2005  Tennessee Society of Health-System Pharmacists’ Distinguished Service Award
• 2002  Excellence in Teaching Award, Student Government Association Executive Council, University of Tennessee College of Pharmacy
• 1996  Tennessee Society of Health-System Pharmacists Hospital Pharmacist of the Year
• 1994  Fellow of the American Society of Health-System Pharmacists
• 1985  Outstanding Clinical Preceptor,. University of Tennessee Doctor of Pharmacy Class of 1985
• 1982  Outstanding Young Men of America
• 1979  Smith, Kline, and French Laboratory Award, University of North Carolina School of Pharmacy

Research Interests

• Medication safety and methods to minimize patient risk
• Pharmacoeconomics
• Pharmacotherapy of infectious disease

Selected Publications

AlFaar AS, Kamal S, AbouElnaga S, Greene WL, Quintana Y, Ribeiro RC, Qaddaoumi IA. International telepharmacy education: another venue to improve cancer care in the developing world. Telemedicine and e-Health Jul;18(6):470-4, 2012. Epub 2012 Jun 5, 2012.

Lobo B, Greene WL. Comment: zolpidem: distinct from triazolam? (reply to letter) Annals of Pharmacotherapy 31:1410-13, 1997.

Lobo B, Greene WL. Insomnia (zolpidem is not superior to triazolam. (letter) New Engl J Med 336:1919, 1997.

Lobo B, Greene WL. Zolpidem: Distinct from triazolam? Annals of Pharmacotherapy 31:625-32, 1997.

Simmons BP, Gelfand MS, Greene WL. Empiric use of amphotericin B and fluconazole for nosocomial fever of unknown origin not responding to antibacterial antibiotics. Infect Dis Clin Pract 6:177-81, 1997.

Bertorini TE, Nance AM, Horner LH, Greene W, Gelfand MS, Jaster JH. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 19:388-91, 1996.

Lobo B, Greene WL. Indicate specific low-molecular-weight heparin product and dosage (letter). Chest 30:866, 1996.

Shorr RI, Greene WL. A food-borne outbreak of expensive antibiotic use in a community teaching hospital (letter). JAMA 273:1908, 1995.

Hoon TJ, Wood CA Jr, Whidden MA, Greene WL, Bottorf MB. The relative predictive performance of two theophylline pharmacokinetic dosing programs. Pharmacotherapy 8:82-88, 1988.

Smith JL, Graham DY, Greene WL, Phelps SJ, Green B. Famotidine: a long-acting H-2 receptor antagonist. Comparison with cimetidine and ranitidine. Hosp Formul 22(suppl B):15-27, 1987.

Greene WL. Calcium channel blockers in airway disease. US Pharmacist 11:H1-H16, 1986.

Greene WL. Cimetidine drug interactions. Rev Drug Metab Drug Interact 5:25-51, 1984.

Greene WL. Cimetidine in stress ulcer prophylaxis. Crit Care Med 12:571-75, 1984.

Greene WL, Self TH, Levinson MJ. Cimetidine drug interactions. J Fam Practice 16:1087-93, 1983.

Last update: February 2013